Predictive factors for the efficacy of the second taxane treatment in patients with advanced cancer
Hiroo Imai(Tohoku University), Chikashi Ishioka(Tohoku University), Sho Umegaki(Tohoku University), Keigo Komine(Tohoku University), Ken Saijo(Tohoku University), Masanobu Takahashi(Shibaura Institute of Technology), Yoshifumi Kawamura(Tohoku University), Shin Takahashi(Institute of Aging), Hidekazu Shirota(Tohoku University), Kota Ouchi(Tohoku University), Sakura Hiraide(Tohoku University Hospital), Yuko Sato(Tohoku University), Yoshinari Okada(Tohoku University), Masahiro Takahashi(Tohoku University Hospital)
Cited by 1
Related Papers
Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1
|Nature|2011|388
MiR‐133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures
|The EMBO Journal|2014|302
Human protein factory for converting the transcriptome into an in vitro–expressed proteome
|Nature Methods|2008|269
Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)
|Journal of Hepato-Biliary-Pancreatic Sciences|2022|244
Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer
|Molecular Cancer Therapeutics|2006|243